Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

U.S. stocks drifted to a mixed finish on Thursday as President Donald Trump’s tariffs taking effect on dozens of countries ...

GLP-1's, which are traditionally diabetes medications, have exploded in popularity since they were approved for weight-loss.

Eli Lilly stock crashes as late-stage data for weight-loss pill falls short of expectations. Analyst explains why data wasn't ...

U.S. stocks reverse most early gains. Fed's Waller reportedly is a top pick to replace Powell as Fed chair. Investors also eye tariffs and earnings.

Results from the Phase III ATTAIN-1 trial (NCT05869903) showed that the highest dose of orforglipron achieved an average ...

Dutch Bros shares are trading higher Thursday after the company posted stronger-than-expected second-quarter 2025 results and ...

The main indexes finished well off their session highs after a disappointing batch of corporate earnings reports.

US stocks trimmed losses on Thursday, finishing mixed after President Trump's sweeping tariffs hit dozens of US trade ...

Lilly Gerrard has shared some adorable snaps of her newborn baby just weeks after giving birth. Steven Gerrard's daughter has ...

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...

U.S. stocks are drifting lower after President Donald Trump’s latest tariffs took effect on dozens of countries, but the moves are modest and stocks rose in much of the rest ...